Twist Bioscience
TWST
118 hedge funds and large institutions have $967M invested in Twist Bioscience in 2020 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 44 increasing their positions, 22 reducing their positions, and 15 closing their positions.
8,943% more call options, than puts
Call options by funds: $633K | Put options by funds: $7K
200% more funds holding in top 10
Funds holding in top 10: 2 → 6 (+4)
180% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 15
133% more capital invested
Capital invested by funds: $414M → $967M (+$553M)
100% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 22
27% more funds holding
Funds holding: 93 → 118 (+25)
17.84% more ownership
Funds ownership: 59.6% → 77.45% (+18%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$61.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$35.7M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$33.4M |
| 4 |
Bank of New York Mellon
New York
|
+$22.7M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$21.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$8.65M |
| 2 |
TCM
Tao Capital Management
San Francisco,
California
|
-$5.67M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$5.63M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$5.47M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.08M |
TWST Hedge Fund Activity: Q1 2020 in Review
118 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q1 2020, worth a combined $967M — up 133% from $414M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new TWST positions and 15 closed out — a net gain of 27 holders — while 44 added to existing stakes and 22 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $61.6M. The largest seller was Millennium Management, cutting an estimated $8.65M.
- 118 institutional investors held Twist Bioscience (TWST) as of Q1 2020, up from 93 in Q4 2019.
- Funds reported $967M of Twist Bioscience stock for Q1 2020, up 133% quarter-over-quarter.
- 42 funds opened new Twist Bioscience positions in Q1 2020 and 15 closed out, a net change of +27 holders.
- The largest Twist Bioscience buyer in Q1 2020 was Fidelity Investments, an estimated $61.6M added.
- The largest Twist Bioscience seller in Q1 2020 was Millennium Management, an estimated $8.65M sold.
Based on aggregated 13F filings for Q1 2020.